Common nephropathies (oxaluria)

Metabolic, or dysmetabolic, nephropathy in a broad sense are diseases associated with severe disturbances in water-salt metabolism and other types of metabolism in the whole body. Dysmetabolic nephropathy in a narrow sense is a polygenically inherited pathology of oxalic acid metabolism and manifests itself in conditions of familial instability of cell membranes. Metabolic nephropathy is divided into primary - the result of kidney damage by products of altered metabolism in the whole body, and secondary, associated with a violation of enzyme systems in the kidneys themselves.

Causes dysmetabolic nephropathy

The causes of dysmetabolic nephropathy can be varied and may include the following factors:

1. Diabetes mellitus: Diabetes is one of the most common causes of dysmetabolic nephropathy. High blood sugar levels can damage the renal vessels and cause chronic kidney disease (nephropathy).
2. Metabolic syndrome: This syndrome includes a combination of risk factors such as obesity, high blood pressure, impaired glucose metabolism, and dyslipidemia (impaired lipid metabolism). Metabolic syndrome may be associated with the development of nephropathy.
3. Hypertension: High blood pressure can negatively affect kidney function and lead to nephropathy.
4. Hyperuricemia: High levels of uric acid in the blood (hyperuricemia) can cause urinary stones and kidney damage.
5. Hypercalcemia: High levels of calcium in the blood can cause kidney stones and damage kidney tissue.
6. Other metabolic disorders: Some rare metabolic disorders such as cystinosis, factory disease, type 1 and type 2 diabetes mellitus, cystic fibrosis and others may be associated with the development of dysmetabolic nephropathy.
7. Drugs and toxins: Certain drugs and chemicals can cause metabolic changes and kidney damage, which can lead to nephropathy.
8. Heredity: Some forms of dysmetabolic nephropathy may be genetic in nature and passed on through families.

To diagnose and treat dysmetabolic nephropathy, it is important to conduct a comprehensive examination of the patient, including blood and urine tests, ultrasound examination of the kidneys, and other diagnostic methods.

Pathogenesis

The pathogenesis of this condition includes a number of mechanisms and processes that lead to damage to renal tissue. Here are the main aspects of the pathogenesis of dysmetabolic nephropathy:

1. Hyperglycemia (high blood glucose): In diabetes, uncontrolled high blood glucose can damage the blood vessels in the kidneys. This leads to poor blood supply to the kidneys and increased filtration pressure in the kidneys.
2. Hypertension (high blood pressure): Hypertension can cause damage to the blood vessels in the kidneys and impair their blood supply. It also increases the workload on the kidneys and can lead to kidney damage.
3. Hyperfiltration: Increased pressure in the kidneys can lead to hyperfiltration, where the glomeruli filter more blood than normal. This puts extra strain on the kidney structures and can cause damage.
4. Inflammation and fibrosis (sclerosis of kidney tissue): In response to kidney injury, an inflammatory response and the formation of connective tissue (fibrosis) occurs, which impairs kidney function.
5. Oxidative and inflammatory processes: The resulting oxidative stress and inflammation can damage kidney cells, including tubules and glomeruli.
6. Endothelial (inner lining of blood vessels) dysfunction: Damage to the vascular endothelium, including the renal arteries and arterioles, can lead to impaired blood flow regulation and damage to kidney tissue.
7. Production of inflammatory and growth mediators (eg, cytokines): High levels of cytokines and other inflammatory mediators may worsen inflammatory processes in the kidneys.

The pathogenesis of dysmetabolic nephropathy is complex and multifaceted. This process can lead to chronic kidney damage, which can ultimately lead to chronic renal failure.

Symptoms dysmetabolic nephropathy

Symptoms of metabolic nephropathy may vary depending on the specific type of disease, but they typically include the following:

1. Renal dysfunction: This is one of the main symptoms of metabolic nephropathy. It may include impaired renal function, which leads to changes in urine formation, fluid and electrolyte retention in the body, and increased levels of creatinine and urea in the blood.
2. Proteinuria: Metabolic nephropathies can cause protein to leak into the urine. This can lead to edema and other symptoms associated with protein loss.
3. Hypercalcemia: Increased calcium levels in the blood can be one of the symptoms. This can cause symptoms such as fatigue, nausea, vomiting, and heart problems.
4. Bone changes: Metabolic nephropathies can affect bone health, causing osteoporosis or osteomalacia (soft and deformed bones).
5. Neurological symptoms: Some metabolic nephropathies can cause neurological symptoms such as developmental delay, muscle weakness, seizures, and others.
6. Other systemic manifestations: Metabolic nephropathies can also affect other organs and systems, causing a variety of symptoms such as damage to the heart, eyes, skin, and other tissues.

It is important to note that the symptoms of metabolic nephropathy can manifest themselves in a variety of ways and depend on the specific type and stage of the disease.

The manifestations of dysmetabolic nephropathy can be associated with various causes and factors. Some of them include:

1. Hypercalcemia: Higher than normal levels of calcium in the blood (hypercalcemia) can contribute to the formation of calcium crystals in the kidneys, which can lead to dysmetabolic nephropathy. Causes of hypercalcemia can include hyperparathyroidism (excess parathyroid hormone), sarcoidosis, hypercalcemic diets, and other conditions.
2. Hypercalciuria: This is a condition in which too much calcium is excreted in the urine. Hypercalciuria can be caused by a problem with calcium regulation in the kidneys or a problem with calcium metabolism in the body.
3. Hyperoxaluria: Elevated levels of oxalate in the urine (hyperoxaluria) can lead to the formation of oxalate kidney stones and cause dysmetabolic nephropathy. Causes of hyperoxaluria may include genetic factors, digestive disorders, and a diet rich in oxalates.
4. Hyperuricosuria: Increased uric acid levels in the urine (hyperuricosuria) can contribute to the formation of uric acid kidney stones and lead to dysmetabolic nephropathy.
5. Hypoxaluria: Hypoxaluria, in which the urine contains too little oxalate, may also be associated with dysmetabolic nephropathy and stone formation.
6. Genetic factors: Some cases of dysmetabolic nephropathy may have a genetic basis, in which metabolic processes in the kidneys are disrupted.

Primary oxaluria

The source of most oxalates is endogenous processes. The precursors of oxalates are glycine, phenylalanine, tyrosine, tryptophan, threonine, asparagine and ascorbic acid. A large endogenous source of oxalates is ethanolamine. Additional conditions for endogenous hyperproduction of oxalates are deficiency of vitamins A, D, B ₆, taurine. All precursors are converted into oxalic acid through glyoxylic acid. Increased absorption of oxalates in the intestine is of certain importance. Clinical forms of primary endogenous disorder of oxalic acid metabolism are oxalosis and hyperoxaluria with nephrolithiasis. Biochemically, two types are distinguished, both inherited automically recessively.

1. Deficiency of glyoxylic acid carbolidase, which catalyzes the conversion of glyoxylate to CO2 _and formic acid. The cofactor for this reaction is thiamine. In this variant of the defect, large amounts of oxalic, glycolic, and glyoxylic acids are excreted in the urine.
2. A defect in the D-glycerate dehydrogenase enzyme system. In such cases, large amounts of oxalic and glyceric acids are excreted in the urine. Both enzyme systems function in the liver. The two variants are not clinically distinguishable.

In both cases, relatives of the probands often have various kidney lesions. The obstetric history of the mother includes prematurity and stillbirth. Oxalosis is more common in boys. The first manifestations of the disease in 65% of patients appear before the age of 5, 80% do not survive to the age of 20. The earlier the disease manifests itself, the worse the prognosis - the shorter the life of the patient. The first manifestations of this pathology are changes in urine tests in the form of proteinuria and hematuria, renal colic is possible, recurrent pyelonephritis. Lithiasis is mainly bilateral, recurrent with coral stones. Delayed physical development, osteoporosis, possible myocardial changes, cardiac conduction disorders, arthralgia. Chronic renal failure quickly develops to the terminal stage. Oxalosis is a rare clinical form of primary oxaluria. A little more than 100 documented cases of generalized oxalosis are described in the literature. Primary isolated hyperoxaluria is much more common. Its course is somewhat milder and chronic renal failure develops later than with oxalosis. However, the prognosis is also poor. Since the defect is localized in the liver enzyme systems, transplantation of an isolated kidney is useless. Attempts are currently being made to transplant a liver-kidney block.

Secondary hyperoxaluria. Calcium oxalate crystalluria

Calcium oxalate crystalluria is a common phenomenon. Several groups of its causes can be distinguished. One of them is increased precipitation of calcium oxalate in urine. Urine is always a saturated solution of calcium oxalate, since at normal urine pH values close to 7 (5.5-7.2), the solubility of calcium oxalate is negligible - 0.56 mg per 100 ml of water. Calcium oxalate reaches its maximum solubility at pH below 3.0. The degree of precipitation depends on the ratio of calcium and oxalates (individuals with hypercalciuria excrete more calcium oxalate); on the presence of magnesium salts (precipitation increases with magnesium deficiency); on excess or deficiency of substances that maintain the colloidal properties of urine (citrates, celiatin, pyrophosphates); on excessive excretion of oxalates.

Excessive excretion of oxalates may be associated with its excessive production (usually not associated with genetically determined defects of liver enzymes), with increased absorption of oxalates in the intestine, and with local formation of oxalates in the renal tubules themselves. Excessive production of oxalates is possible under conditions of deficiency of vitamins A and D, as well as with exogenous deficiency or endogenous disorder of pyridoxine metabolism. In this case, a deficiency of taurine and taurocholic acids develops and, as a consequence, the metabolism of glycocholic acid changes towards excessive production of oxalate. Oxalate stones are common in patients with impaired uric acid metabolism (hyperuricemia). 80% of patients with gout have an increased concentration of oxalic acid in the blood.

Increased intestinal absorption of oxalates may be due to high consumption of foods rich in oxalic acid salts. These include leafy vegetables (lettuce, sorrel, spinach), tomato and orange juice, and beets. A genetically determined enterooxalate syndrome, or Locke's syndrome, has been described, in which increased intestinal absorption of oxalates depends little on their consumption. Localized formation of oxalates in the kidneys is the most common cause of moderate oxaluria and increased crystal formation in the urine. It is known that cell membranes, including those of the tubular epithelium, consist of interpenetrating layers of proteins and phospholipids. The outer layer of the cell membrane facing the lumen of the tubule is formed mainly by phosphatidylserine and phosphatidylethanolamine. When phospholipases are activated, nitrogenous bases (seri and ethanolamine) are split off from the membrane and converted into oxalate by a short metabolic chain. The latter combines with calcium ions and is converted into calcium oxalate. Activation of endogenous or the appearance of bacterial phospholipases is an integral component of the inflammatory reaction. Increased excretion of calcium oxalate and crystalluria are always present in the urine of patients in the active phase of pyelonephritis, which does not allow diagnosing dysmetabolic nephropathy by the oxaluria type until the inflammation subsides. Increased phospholipase activity always accompanies renal ischemia of any nature and the processes of activation of protein and lipid peroxidation. Instability of cell membranes with increased phospholipase activity is a condition described as a polygenically inherited trait. Hyperoxaluria and crystalluria often accompany any manifestations of allergosis, especially respiratory allergosis. The presence of oxalate diathesis is discussed.

Markers of calciphylaxis: phospholipiduria, increased excretion of ethanolamine in urine, high activity of phospholipase C in urine, increased excretion of crystal-forming anions - oxalates and phosphates.

[ 1 ], [ 2 ], [ 3 ], [ 4 ], [ 5 ], [ 6 ], [ 7 ]

Stages

This condition can develop gradually and go through several stages, from initial changes to more serious kidney damage. The following stages of dysmetabolic nephropathy are generally recognized:

1. Initial stage (stage 1):

   • At this stage, changes in the kidneys usually do not yet cause significant symptoms.
   • Laboratory tests of urine and blood may show some abnormalities, such as protein in the urine (proteinuria) or a slightly elevated creatinine level in the blood.
   • It is important to begin controlling risk factors such as blood glucose levels, blood pressure, and lipid levels to prevent disease progression.

2. Subclinical nephropathy stage (stage 2):

   • At this stage, changes in the kidneys may be more pronounced, but patients often experience no symptoms.
   • Proteinuria (protein in the urine) continues, and blood creatinine levels may increase.
   • Control of metabolic risk factors remains important to slow disease progression.

3. Stage of clinical nephropathy (stage 3):

   • At this stage, clinical symptoms such as swelling, fatigue, lower back pain and high blood pressure may appear.
   • Proteinuria becomes more pronounced.
   • Kidney function may be impaired, as evidenced by increased blood creatinine levels and decreased glomerular filtration rate (GFR).

4. Stage of chronic renal failure (stage 4):

   • At this stage, kidney function is significantly impaired, which can cause serious symptoms and complications.
   • The level of creatinine in the blood is significantly elevated.
   • Patients may experience severe abdominal pain, nausea, vomiting, anemia and other symptoms.

5. Stage 5 of end-stage renal failure:

   • In this late stage, kidney function is completely impaired and patients require ongoing support, such as dialysis or kidney transplant, to survive.

Controlling metabolic risk factors, including blood glucose levels, blood pressure, lipid levels, and uric acid levels, as well as regular medical monitoring, can help slow the progression of dysmetabolic nephropathy and prevent it from progressing to more serious stages.

Forms

Dysmetabolic nephropathy is a general term that describes kidney damage due to metabolic disorders such as diabetes and hypertension. Depending on the underlying metabolic disorder and the extent to which it affects the kidneys, different forms of dysmetabolic nephropathy may develop. Some of them are:

1. Diabetic nephropathy: This is one of the most common forms of dysmetabolic nephropathy and is associated with diabetes mellitus. High blood glucose levels damage the small blood vessels of the kidneys (glomeruli), leading to poor kidney function.
2. Hypertensive nephropathy: Hypertension (high blood pressure) can cause damage to the blood vessels in the kidneys and impair their blood supply. This can lead to the development of hypertensive nephropathy.
3. Obesity-associated nephropathy: Obesity can increase the risk of developing chronic kidney disease. It can cause hyperfiltration of the kidneys and damage their structures.
4. Metabolic syndrome: This syndrome combines several risk factors, including obesity, hyperglycemia, hypertension, and lipid metabolism disorders. Metabolic syndrome may increase the risk of developing nephropathy.
5. Other forms of metabolic nephropathy: In addition, metabolic disorders such as hyperlipidemia (high levels of lipids in the blood) and uric acid metabolism disorders can lead to the development of specific forms of dysmetabolic nephropathy.

Each of these forms may have its own characteristic clinical and laboratory manifestations.

Complications and consequences

Dysmetabolic nephropathy, as a result of metabolic disorders and kidney damage, can lead to various complications and serious health problems. Some of the possible complications associated with this condition are listed below:

1. Chronic kidney failure: Long-term metabolic disturbances and damage to the kidneys can lead to a gradual decline in kidney function and eventually to chronic kidney failure. This means that the kidneys are no longer able to fully perform their functions of cleaning the blood and removing excess waste from the body.
2. Proteinuria: Damage to the glomeruli of the kidneys can cause protein to leak into the urine (proteinuria). Proteinuria may be the first sign of kidney dysfunction and can lead to more serious complications.
3. Acute or chronic pyelonephritis: Inflammation of the kidney tissue (pyelonephritis) can occur as a complication of dysmetabolic nephropathy, especially when there is a disruption in the outflow of urine from the kidneys or urinary infections.
4. Acute ischemic nephritis: This condition is associated with impaired blood supply to the kidneys, which can occur with atherosclerosis of the renal vessels, which can be associated with dysmetabolic nephropathy.
5. Urolithiasis: The buildup of certain substances in the kidneys can contribute to the formation of urinary stones, which can cause obstruction of the urinary tract and lead to pain and urinary tract infections.
6. Cardiovascular complications: Patients with dysmetabolic nephropathy have an increased risk of developing cardiovascular diseases such as atherosclerosis and hypertension.
7. Pregnancy complications: Women with dysmetabolic nephropathy may experience pregnancy complications such as preeclampsia and gestational diabetes.
8. Neurological complications: Patients with chronic renal failure caused by dysmetabolic nephropathy may develop neurological complications such as peripheral neuropathy.

Patients with dysmetabolic nephropathy should regularly monitor their condition under the supervision of a physician and follow recommendations for monitoring metabolic parameters, diet, physical activity, and treatment. Early detection and treatment of complications can help improve the prognosis and quality of life of the patient.

Diagnostics dysmetabolic nephropathy

Diagnosis of dysmetabolic nephropathy includes a number of clinical and laboratory methods that help to identify the presence of this condition and determine its severity. The main diagnostic methods are listed below:

1. History and physical examination: The physician will discuss the patient's medical and family history, including the presence of diabetes, hypertension, obesity, and other metabolic disorders. The physical examination will include an assessment of blood pressure and kidney function.
2. Urinalysis: A complete urine analysis (urinalysis) can reveal protein, glucose, red blood cells, and other abnormalities that may be signs of kidney damage.
3. Blood test: Blood tests measure levels of creatinine and urea to assess kidney function. Elevated levels of these substances may indicate deterioration in kidney function.
4. Glomerular filtration rate (GFR) test: This is a special test that measures the rate at which the kidneys filter the blood. The normal GFR is about 90-120 ml/min/1.73 m². A decrease in this rate may indicate impaired kidney function.
5. Renal ultrasound: Renal ultrasound allows visualization and evaluation of the renal structures and vessels. This can help identify abnormalities or changes associated with dysmetabolic nephropathy.

Dysmetabolic nephropathy on ultrasound examination (US) can manifest itself with various echographic signs that may indicate changes in the renal tissue and structure of the kidneys. However, it should be remembered that ultrasound is not an exclusively diagnostic method for dysmetabolic nephropathy, and the final diagnosis requires additional clinical and laboratory data. Here are some possible echographic signs of dysmetabolic nephropathy on ultrasound:

• Changes in kidney size: Dysmetabolic nephropathy can cause changes in kidney size. Usually, the kidneys are close to normal in size, but in some cases, they may be enlarged (hypertrophy) or smaller (atrophy).
• Hyperechogenicity: This change is characterized by a brighter echo density of the renal tissue on ultrasound. Hyperechogenicity may be due to the presence of calcifications (stones) in the kidneys or other changes in the tissue.
• Irregular structure: Dysmetabolic nephropathy can result in irregular structure of the kidneys, which may appear as irregular areas of hyperechogenicity or other changes in tissue texture.
• Dilation of the renal pelvis: Some forms of dysmetabolic nephropathy can cause dilation (widening) of the renal pelvis, which may be visible on ultrasound.
• Increased echo density of the cortex: Increased brightness of the cortical zone of the kidney may be associated with dysmetabolic changes.

Please note that echographic signs may vary depending on the specific form of dysmetabolic nephropathy and the stage of the disease. A comprehensive examination, including blood and urine tests, as well as consultation with a nephrologist or urologist, is required to clarify the diagnosis and assess the extent of kidney damage. Ultrasound is an important tool for the initial assessment of the kidney condition and may refer for additional studies.

6. Additional tests: Depending on your clinical symptoms and previous test results, your doctor may order additional tests, such as urine tests for microalbuminuria (protein in the urine) or a kidney biopsy.

Diagnosis of dysmetabolic nephropathy is a complex process, and the physician determines the need for certain tests based on clinical data and the patient's history. Early detection and diagnosis of this condition are important for timely initiation of treatment and management of risk factors to prevent progression of renal impairment.

Differential diagnosis

Differential diagnosis of dysmetabolic nephropathy involves identifying this condition and excluding other pathologies that may have similar symptoms or laboratory changes. Below are some diseases and conditions that should be considered in the differential diagnosis of dysmetabolic nephropathy:

1. Polycystic kidney disease: This is a genetic disorder in which cysts form in the kidneys, which can lead to chronic kidney failure and other symptoms similar to dysmetabolic nephropathy.
2. Underlying renal disease: Other primary renal diseases, such as glomerulonephritis or tubulopathies, may cause similar symptoms and laboratory changes.
3. Hypertension: High blood pressure can cause kidney damage and protein in the urine, which can simulate dysmetabolic nephropathy.
4. Urinary tract infections: Urinary tract infections can cause low back pain and changes in urine similar to those of dysmetabolic nephropathy.
5. Other metabolic disorders: Some metabolic diseases, such as kidney stones or hypercalcemia, can also affect kidney function and cause similar symptoms.
6. Secondary renal complications: Dysmetabolic nephropathy may be accompanied by other diseases such as diabetic nephropathy, which can complicate the differential diagnosis.

The following methods and studies may be required for differential diagnosis:

• Laboratory tests of urine and blood, including measurement of creatinine, urine protein, and other biochemical parameters.
• Ultrasound examination of the kidneys and urinary tract.
• Kidney biopsy, if necessary to clarify the diagnosis.
• Genetic testing if polycystic kidney disease or other genetic disorders are suspected.

For an accurate diagnosis and determination of the cause of kidney disorders, it is important to undergo a comprehensive examination under the guidance of an experienced nephrologist or urologist.

Treatment dysmetabolic nephropathy

Treatment of dysmetabolic nephropathy depends on the underlying metabolic disorder or disease that has caused the condition. The main goals of treatment are to control metabolic risk factors, maintain kidney function, and prevent further deterioration of the condition. Here are some general approaches to treating dysmetabolic nephropathy:

1. Management of diabetes: If dysmetabolic nephropathy is associated with diabetes, it is important to achieve and maintain good blood glucose control. This may include insulin, oral antiglycemic agents, and a carbohydrate-restricted diet.
2. Blood pressure control: Managing blood pressure is a key part of treatment, as high blood pressure can impair kidney function. Your doctor may prescribe antihypertensive medications and recommend lifestyle changes, such as limiting salt and getting regular exercise.
3. Diet: A diet is recommended that can help control blood sugar, blood pressure, and calcium levels. A dietitian can help develop a diet that is appropriate for each patient.

Plentiful fluid intake is prescribed (up to 2 liters per 1.73 m2 ⁾, especially in the evening, before bedtime. A potato-cabbage diet is recommended, rich in potassium, poor in oxalic acid salts. Products containing large amounts of oxalates (leafy vegetables, beets, tomato and orange juice) are limited. Products enriched with potassium and magnesium are useful - dried fruits, bran bread, pumpkin, squash, eggplant, dogwood, as well as fresh unsweetened fruits.

4. Medications: In some cases, your doctor may prescribe medications, such as water pills (diuretics), to help manage fluid and electrolyte levels in your body.

Drug therapy involves prescribing monthly courses of membrane stabilizers in spring and autumn - the seasons of natural increase in oxaluria. Vitamins A, B6 _, complex preparations containing vitamin E in combination with other components of the antioxidant system, as well as small doses of magnesium (panangin or asparkam) are prescribed. In case of pronounced and persistent hyperoxaluria, courses of dimephosphates are indicated - xydiphone or dimephosphone.

5. Genetic counseling: If dysmetabolic nephropathy is genetic in nature, genetic counseling and testing may be helpful in determining the genetic basis of the disease and developing an appropriate treatment plan.
6. Regular monitoring: Patients with dysmetabolic nephropathy should be regularly monitored by doctors to monitor the condition of the kidneys, the level of metabolic parameters and the effectiveness of treatment.

Treatment of dysmetabolic nephropathy requires an individual approach and may involve several aspects of disease and symptom management. It is important for patients to collaborate with their healthcare professionals and follow their recommendations to achieve the best results.

Prevention

Prevention of dysmetabolic nephropathy is aimed at managing major metabolic risk factors such as diabetes, hypertension, and obesity to prevent kidney damage. Some key preventive measures include:

1. Controlling your blood glucose: If you have diabetes, it is important to follow your doctor's recommendations for controlling your blood glucose. This includes checking your blood sugar regularly, taking your prescribed medications (if prescribed), following a low-carbohydrate diet, and being physically active.
2. Blood pressure control: Hypertension (high blood pressure) is one of the major risk factors for developing nephropathy. Regular blood pressure monitoring, following a low-salt diet, taking prescribed antihypertensive medications (if prescribed), and being physically active can help control blood pressure.
3. Obesity: If you are obese, working to lose weight may reduce your risk of developing kidney disease. Developing a weight loss plan with your doctor and dietitian can help you achieve this goal.
4. Healthy lifestyle: Maintain a healthy lifestyle, including a healthy diet that limits sugar, salt and fat, regular physical activity, not smoking and drinking alcohol in moderation.
5. Treatment and management of other metabolic disorders: If you have other metabolic disorders, such as hyperlipidemia (high blood lipids) or uric acid disorders, follow your doctor's recommendations for treatment and management.
6. Regular medical checkups: It is important to see your doctor regularly for medical checkups and monitoring of your kidney health and metabolic parameters.
7. Compliance with Prescriptions: If you are prescribed medications to control diabetes, high blood pressure, or other metabolic disorders, follow your doctor's instructions and take them as prescribed.

Prevention of dysmetabolic nephropathy is important to maintain kidney health and prevent the development of chronic kidney disease. It is important to consult a doctor in a timely manner to assess the risk and develop individual recommendations for prevention, especially if you have risk factors for this condition.

Forecast

The prognosis of dysmetabolic nephropathy depends on many factors, including the degree of kidney damage, the presence of comorbid medical conditions, and the effectiveness of treatment. It is important to understand that dysmetabolic nephropathy often develops slowly and gradually, and early detection and control of metabolic risk factors can significantly improve the prognosis.

The prognosis can be assessed at different stages of dysmetabolic nephropathy:

1. Initial stage: At this stage, changes in the kidneys may be mild and may be completely reversible with proper control of metabolic parameters. The prognosis in this case is often favorable.
2. Subclinical nephropathy stage: If deterioration in kidney function is detected but patients are still asymptomatic, following treatment recommendations and risk factor control may slow disease progression.
3. Clinical nephropathy stage: Symptoms and complications may occur at this stage, and the prognosis depends on the extent of kidney damage and the effectiveness of treatment. Early treatment and consultation can help prevent serious complications.
4. Chronic renal failure stage: As the disease progresses to this stage, the prognosis may be less favorable. Patients may require ongoing medical support, including dialysis or kidney transplantation.

5. End-stage renal failure: At this stage, kidney function is completely impaired and the prognosis is grave. Kidney transplantation is the most effective treatment.

It is important to remember that regular medical examinations and adherence to doctor's recommendations can significantly improve the prognosis for patients with dysmetabolic nephropathy. Controlling blood glucose levels, blood pressure, lipid levels and other metabolic parameters, as well as following a diet and physical activity regimen, can help slow the progression of the disease and prevent its complications.

Clinical guidelines for the management of dysmetabolic nephropathy

Dysmetabolic nephropathy is a condition in which kidney function is impaired due to metabolic disorders such as diabetes or hypertension. It is important to note that treatment for dysmetabolic nephropathy requires a comprehensive approach and is prescribed by a doctor depending on the specific situation and the extent of kidney damage. However, below are general clinical guidelines that can help in managing this condition:

1. Blood glucose control (in diabetes): If dysmetabolic nephropathy is associated with diabetes, it is important to strictly control blood glucose levels. This may require taking hypoglycemic drugs or insulin.
2. Blood pressure control: Hypertension (high blood pressure) is one of the most common causes of dysmetabolic nephropathy. Measure your blood pressure regularly and follow your doctor’s recommendations for antihypertensive therapy and a low-salt diet.
3. Diet: Following a special diet can be an important aspect of treating dysmetabolic nephropathy. Your doctor or dietitian may recommend limiting your intake of protein, salt, and certain other foods depending on your kidney health.
4. Managing blood lipids: If you have high cholesterol or triglycerides, treatment with statins or other lipid-lowering medications may be recommended by your doctor.
5. Treatment of the underlying disease: If dysmetabolic nephropathy is associated with other metabolic disorders such as obesity or hyperlipidemia, treatment of the underlying disease may be a key aspect of managing the condition.
6. Regular medical checkups: Regular visits to your doctor and necessary lab tests will help monitor your kidney health and the effectiveness of treatment.
7. Physical activity: Under the supervision of a doctor, physical activity can be helpful for maintaining overall health and managing risk factors.
8. Support for psychosocial well-being: Since dysmetabolic nephropathy can have a psychological impact on the patient, it is important to provide support and consultation with a psychologist or psychiatrist if necessary.

Following these recommendations and working with your doctor will help manage dysmetabolic nephropathy and reduce the risk of its progression. It is important to consult with your doctor to develop an individualized treatment plan and monitor your condition.